Advertisements


Alnylam confirms FDA approves Onpattro to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam"s Onpattro approved by FDA to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic

Alnylam (ALNY) receives FDA approval for Onpattro to treat polyneuropathy of hereditary transthy.....»»

Category: dealsSource: nytAug 13th, 2018

FDA approves Alnylam"s Onpattro as hATTR treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

FDA Approves $450,000-a-Year Treatment for Rare Disease

Patients who have hereditary transthyretin-mediated amyloidosis, or hATTR, will take the drug for the rest of their lives. Alnylam Phar.....»»

Category: europeSource: fortuneAug 11th, 2018

Alnylam Pharmaceutical"s (ALNY) Conference Call to Discuss FDA Approval of ONPATTRO (Patisiran) - Slideshow

Alnylam Pharmaceutical"s (ALNY) Conference Call to Discuss FDA Approval of ONPATTRO (Patisiran) - Slideshow.....»»

Category: topSource: seekingalphaAug 13th, 2018

Alnylam rare drug gets FDA approval, to cost $345,000 on average

Alnylam Pharmaceuticals Inc.'s rare disease drug Onpattro has been approved by the Food and Drug Administration, marking the first approval of a therapy that employs the RNA interference (RNAi) gene-silencing technique. Onpattro, also called patis.....»»

Category: topSource: marketwatchAug 11th, 2018

Alnylam rare drug gets FDA approval, to cost $345,000 on oaverage

Alnylam Pharmaceuticals Inc.'s rare disease drug Onpattro has been approved by the Food and Drug Administration, marking the first approval of a therapy that employs the RNA interference (RNAi) gene-silencing technique. Onpattro, also called patis.....»»

Category: topSource: marketwatchAug 10th, 2018

Alnylam expects Germany to be first EU launch country for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam says Onpattro to be available from two specialty pharmacies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam sees annual average list price before discounts of Onpattro of $450,000

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam announces alignment on value-based agreements for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam tells Bloomberg will work with FDA to get broader claims for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Siga Technologies up 7% after FDA approves TPOXX to treat smallpox

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

FDA Approves Qbrexza, the First-Ever Prescription Treatment for Excessive Sweating

The topical underarm treatment will be available starting in October. The first-of-its-kind drug to treat excessive sweating has been approved by the Federal Drug Administration (FDA). The vexingly spelled Qbre.....»»

Category: europeSource: fortuneJul 2nd, 2018

FDA Approves Drug to Treat Sweaty Armpits

The wipe can be rubbed over the skin daily to block sweat glands from activating......»»

Category: topSource: newsweekJun 29th, 2018

Trump approves individual assistance for Kauai, Oahu flood victims

The Trump administration approved Hawaii Gov. David Ige’s request for individual assistance for victims of the heavy rains that caused severe flooding and landslides on Oahu and Kauai in April, after the Federal Emergency Management Agency previou.....»»

Category: topSource: bizjournalsJun 27th, 2018

Marijuana for Seizures: FDA Approves Drug Made From Pot to Treat Debilitating Epilepsy in Children

The drug, which contains CBD oil, could significantly improve the lives of child seizure sufferers who have rare forms of epilepsy......»»

Category: topSource: newsweekJun 25th, 2018

Marijuana for Seizures: FDA Approves Drug Made from Pot to Treat Debilitating Epilepsy in Children

The drug, which contains CBD oil, could significantly improve the lives of child seizure sufferers who have rare forms of epilepsy......»»

Category: topSource: newsweekJun 25th, 2018

Merck confirms FDA approves Keytruda as second-line option for cervical cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Europe Approves Expanded Label for Amgen Drug

The European Commission gives approval to a drug that is used to treat cardiovascular diseaseRelated Stocks: AMGN,.....»»

Category: smallbizSource: nytMay 17th, 2018